|
Cystitis
|
0.200 |
Biomarker
|
disease |
RGD |
Multiplex analysis of urinary cytokine levels in rat model of cyclophosphamide-induced cystitis.
|
18848347 |
2009 |
|
Enterobacteriaceae Infections
|
0.200 |
Biomarker
|
group |
RGD |
Suppression of the granulocyte colony-stimulating factor response to Escherichia coli challenge by alcohol intoxication.
|
9835289 |
1998 |
|
Lung diseases
|
0.200 |
Biomarker
|
group |
RGD |
Hemorrhagic shock induces G-CSF expression in bronchial epithelium.
|
9374735 |
1997 |
|
Infarction, Middle Cerebral Artery
|
0.200 |
Biomarker
|
disease |
RGD |
Induction of granulocyte colony-stimulating factor mRNA by focal cerebral ischemia and cortical spreading depression.
|
15530654 |
2004 |
|
Neutropenia
|
0.400 |
AlteredExpression
|
disease |
LHGDN |
Endogenous granulocyte colony-stimulating factor (G-CSF) levels in chemotherapy-induced neutropenia and in neutropenia related with primary diseases.
|
12636092 |
2002 |
|
Sepsis
|
0.400 |
Biomarker
|
disease |
LHGDN |
Temporal alterations in concentrations of sera cytokines/chemokines in sepsis due to group B streptococcus infection in a neonate.
|
18806347 |
2008 |
|
Sepsis
|
0.400 |
Biomarker
|
disease |
LHGDN |
Peaks of endogenous G-CSF serum concentrations are followed by an increase in respiratory burst activity of granulocytes in patients with septic shock.
|
12027409 |
2002 |
|
Bladder Neoplasm
|
0.330 |
Biomarker
|
disease |
LHGDN |
Granulocyte colony-stimulating factor/granulocyte colony-stimulating factor receptor biological axis promotes survival and growth of bladder cancer cells.
|
17572226 |
2007 |
|
Bladder Neoplasm
|
0.330 |
AlteredExpression
|
disease |
LHGDN |
To examine the association of granulocyte colony-stimulating factor (G-CSF) and G-CSF receptor (G-CSFR) expression with increased beta1-integrin expression and determine the ability of autocrine G-CSFR signaling to promote bladder cancer cell adhesion by way of beta1-integrin. beta1-integrin is expressed at higher levels in more invasive bladder carcinoma cells and participates in the process of tissue invasion.
|
14751388 |
2004 |
|
Myocardial Infarction
|
0.100 |
AlteredExpression
|
disease |
LHGDN |
Endogenous G-CSF and CD34+ cell mobilization after acute myocardial infarction.
|
16051386 |
2006 |
|
Cerebrovascular accident
|
0.100 |
AlteredExpression
|
group |
LHGDN |
Granulocyte-colony stimulating factor (G-CSF) and G-CSF receptor expression in human ischemic stroke.
|
17047971 |
2007 |
|
MYELODYSPLASTIC SYNDROME
|
0.100 |
Biomarker
|
group |
LHGDN |
Granulocyte colony-stimulating factor and interleukin-6 production by myelodysplastic syndrome blasts.
|
18297540 |
2008 |
|
MYELODYSPLASTIC SYNDROME
|
0.100 |
Biomarker
|
group |
LHGDN |
Treatment with erythropoietin in combination with granulocyte colony-stimulating factor (G-CSF) may synergistically improve the anemia in patients with MDS, with a concomitant decrease in the number of apoptotic bone marrow precursors.
|
12393561 |
2003 |
|
Squamous cell carcinoma
|
0.030 |
Biomarker
|
disease |
LHGDN |
Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo.
|
16912178 |
2006 |
|
Lung Neoplasms
|
0.010 |
AlteredExpression
|
group |
LHGDN |
Role of protein kinase C in expression of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells.
|
16211258 |
2005 |
|
Septic Shock
|
0.010 |
Biomarker
|
phenotype |
LHGDN |
Peaks of endogenous G-CSF serum concentrations are followed by an increase in respiratory burst activity of granulocytes in patients with septic shock.
|
12027409 |
2002 |
|
Infection
|
0.010 |
Biomarker
|
group |
LHGDN |
Temporal alterations in concentrations of sera cytokines/chemokines in sepsis due to group B streptococcus infection in a neonate.
|
18806347 |
2008 |
|
White Blood Cell Count procedure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
|
27863252 |
2016 |
|
White Blood Cell Count procedure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic analyses of diverse populations improves discovery for complex traits.
|
31217584 |
2019 |
|
Neutrophil count (procedure)
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
|
27863252 |
2016 |
|
Eosinophil count procedure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
|
27863252 |
2016 |
|
Blood basophil count (lab test)
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
|
27863252 |
2016 |
|
Granulocyte count
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
|
27863252 |
2016 |
|
Malignant neoplasm of breast
|
0.400 |
Therapeutic
|
disease |
CTD_human |
Weekly cisplatin, epirubicin, and paclitaxel with granulocyte colony-stimulating factor support vs triweekly epirubicin and paclitaxel in locally advanced breast cancer: final analysis of a sicog phase III study.
|
17047649 |
2006 |
|
Malignant neoplasm of breast
|
0.400 |
Biomarker
|
disease |
CTD_human |
Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting.
|
7692001 |
1993 |